Tramadol associated with increased risk of hospitalization for hypoglycemia
12/08/2014
The opioid pain-reliever tramadol appears to be associated with an increased risk of hospitalization for hypoglycemia, a potentially fatal condition caused by low blood sugar, according to a report...
Hodgkin lymphoma responds to immunotherapy
12/08/2014
Two trials show promising results in Hodgkin lymphoma patients treated with immunotherapy drugs that helped their immune system recognize and attack their blood cancer.
Scientists pinpoint a new line of defence used by cancer cells
12/08/2014
Cancer Research UK scientists have discovered a new line of defence used by cancer cells to evade cell death, according to research published in Nature Communications* today (Monday).
Tasman divide remains in cancer survival
12/08/2014
The latest systematic comparison of cancer survival between Australia and New Zealand shows more than 750 New Zealanders who die of cancer each year would survive if they lived on the other side of...
VAXIMM reports positive follow-on data from oral cancer vaccine trial
12/08/2014
VAXIMM AG, a Swiss-German biotech company focusing on oral cancer vaccines, announced today follow-on data from the first clinical trial of its investigational oral T-cell vaccine VXM01.
First and only treatment for multicentric Castleman's disease, SYLVANT, now approved in Canada
12/08/2014
Janssen Inc. has announced that Health Canada has approved SYLVANTTM (siltuximab) for the treatment of patients with multicentric Castleman's disease (MCD) who are human immunodeficiency virus...
FDA approves Jakafi to treat patients with a chronic type of bone marrow disease
12/08/2014
The U.S. Food and Drug Administration have approved a new use for Jakafi (ruxolitinib) to treat patients with polycythemia vera, a chronic type of bone marrow disease.
XTANDI TM(enzalutamide) is now licensed in Europe and is already funded in England on the Cancer Drugs Fund,2 for the treatment of adult men with metastatic castration-resistant prostate cancer...
Weak cells condemned to death by the innate immune system
12/08/2014
The "survival of the fittest" principle applies to cells in a tissue - rapidly growing and dividing cells are the fit ones.
Association between common prostate cancer treatment and decreased survival in older men
12/08/2014
A common prostate cancer therapy should not be used in men whose cancer has not spread beyond the prostate, according to a new study led by researchers at Henry Ford Hospital.